Behavioral, dietary and pharmacological modalities of cardioprotection
Behavioral, dietary and pharmacological modalities of cardioprotection
批准号:
7964069
负责人:
Mark Talan
金额:
$19.2万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Acute myocardial infarctionAffectAgeAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisApoptoticAreaAttenuatedBehavioralBiological FactorsBlueberriesCaliberCaloric RestrictionCardiacCardiac MyocytesCardiovascular PhysiologyCardiovascular systemCellsChronicCoronaryCoronary arteryCouplingDeveloped CountriesDevelopmentDiabetes MellitusDiastoleDiastolic heart failureDietDiseaseDobutamineEFRACEchocardiographyElderlyEvaluationEventExperimental ModelsExposure toFastingFibrosisFoodFood deprivation (experimental)Functional disorderHarvestHeartHeart AtriumHeart failureHistologicHourHumanHypertrophyIn Situ Nick-End LabelingIncidenceInflammationInflammatory ResponseInjuryIschemiaIschemic Brain InjuryKidney DiseasesLeftLeft Ventricular FunctionLeft Ventricular RemodelingLigationLongevityMalignant NeoplasmsMeasurementMeasuresMediatingMitochondriaModalityMorbidity - disease rateMuscle CellsMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumNeurologicOperative Surgical ProceduresPermeabilityPlayPropertyPumpRattusReactive Oxygen SpeciesReperfusion InjuryReportingRiskRodent ModelRoleSignal PathwayStress TestsTestingTherapeutic AgentsTimeTissuesTreatment ProtocolsVentricularWithdrawaladiponectinageddesigndietary antioxidantfeedingfitnessfruits and vegetablesglycemic controlhemodynamicsimprovedindexinginterestinterstitialmalemorphometrymortalitymyocardial infarct sizingnovelpre-clinicalpressureprogramsresearch studysuccesstranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The broad objective of this program is to perform preclinical experimentation on rodent models of myocardial ischemia to test the effect of dietary manipulations prior to ischemic event to increase the tolerance of the cardiac tissue to ischemic damage.
I. Intermittent Fasting (IF), i.e., the feeding regimen when ad lib food is available only every other day, had been reported to increase the life span and to reduces the incidence of age-associated diseases including cancer, diabetes and kidney disease. Neuroprotective effects of IF against ischemic injury of the brain have also been reported. We investigated the cardioprotective effect of IF in rats using the model of experimental myocardial infarction induced by a permanent coronary ligation. After three months of IF or regular, daily, feeding ad libitum (AF), 5-mo old rats were subjected to coronary ligation or sham operation. A subset of rats was sacrificed 24 hours later to measure the size of myocardial infarction (MI) and the extent of apoptosis. The remainder of the animals were continued for 10 weeks on the same food regimen, during which time the progression of left ventricular (LV) remodeling was assessed by serial echocardiography. After ten weeks LV function was measured by pressure-volume loops analyses, and hearts were evaluated histologically. We showed that 24 hrs following coronary ligation the ischemic area of myocardium, i.e., the area at risk (AAR), was similar in both groups, but in IF rats MI size, expressed as a percent of AAR, was more than 2-fold smaller, apoptosis in the AAR was reduced by more than 4-fold, and the inflammatory response was significantly reduced. At 10-wks, late LV remodeling and MI expansion occurred in AF rats but not in IF rats, and LV pump function and arterio-ventricular coupling were superior in IF vs AF rats. The myocyte hypertrophy in areas remote from the MI was also absent in IF rats. The results indicate that Intermittent Food Deprivation protects the heart from ischemic injury in part, at least, via an enhanced anti-apoptotic mechanism. In the last experiments we demonstrated that IF improves glycemic control and results in the increase of the levels of circulating adiponectin. Because recent studies have shown that adiponectin can protect the heart against ischemic injury, adiponectin may mediate, at least in part, the cardioprotective effect of IF.
While tissue protective properties of IF have been proven, the effects chronic IF on general cardiovascular fitness remained unknown. At 4-mo of age male SD rats were started on IF or continued on ad libitum diets. Heart morphometry and function was followed for 6 months with serial echocardiography. At the end of the observation period rats were subjected to a comprehensive hemodynamic evaluation via pressure-volume loop analyses including a combined dobutamine - volume stress test, and hearts were harvested for histological assessment. The six-month long IF resulted in a 9% reduction (p<0.01) of cardiomyocyte diameter and 3 fold increase in interstitial myocardial fibrosis. Left ventricular chamber size was not affected in IF and ejection fraction was not reduced. Left atrial diameter was 16% increased in IF while E/A ratio in Doppler-measured mitral flow was reduced. Pressure-volume loop analyses in IF revealed a stiff heart during diastole, and histological analyses demonstrated a 3-fold increase of myocardial fibrosis vs control hearts. Combined dobutamine and volume loading showed a significant reduction in LV diastolic compliance and a lack of increase in systolic pump function in IF, indicating a diminished cardiac reserve. Thus chronic IF in rats results in development of diastolic dysfunction with diminished cardiac reserve. Therefore, IF is a novel and unique experimental model of behaviorally induced diastolic heart failure. The deleterious effect of IF in rats warrants additional studies of IF effect on cardiovascular functions in humans.
II. Blueberry supplement. Reactive oxygen species (ROS) play a major role in ischemia-related myocardial injury. However, the attempts to use synthetic antioxidants to block the detrimental effects of ROS have produced mixed or negative results precipitating the interest in antioxidants found in natural products. Blueberries have the highest antioxidant capacity among fruits and vegetables, and had been shown to reduce neurological deficits observed in aged animal models. The objective of this study was to assess the cardioprotective properties of a blueberry enriched diet (BD). Following 3-mo exposure to BD or a regular control diet (CD), the threshold for mitochondrial permeability transition (tMPT) was measured in isolated cardiomyocytes obtained from young male Fischer-344 rats. Compared to CD, BD resulted in a 24% increase (p<0.001) of ROS indexed tMPT. The remaining animals were subjected to a permanent ligation of descending coronary artery. 24 hrs later resulting myocardial infarction (MI) in rats on BD was 24% less than in CD rats (p<0.05). Significantly less TUNEL(+) cardiomyocytes (2% vs 9%) and 40% less inflammation cells were observed in the myocardial area at risk of BD compared to CD rats (p<0.05). In other groups of rats, immediately after coronary ligation, the original diet was either continued or switched to the opposite one, and their cardiac remodeling and MI expansion were followed by serial echocardiography for 10 weeks. Results of echo measurements indicated that rates of post MI cardiac remodeling and MI expansion were proportional to original myocardial damage governed by the previous diet. However, BD or its withdrawal after MI induction, attenuated or accelerated this effect. We concluded that a blueberry-enriched diet protected the myocardium from ischemic damage and demonstrated the potential to attenuate the development of post MI chronic heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Different Therapeutic Approaches forTreatment of Chronic Heart Failure
-
批准号:7964059
-
项目类别:
-
资助金额:$42.02万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:8552489
-
项目类别:
-
资助金额:$34.89万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:7732335
-
项目类别:
-
资助金额:$7.59万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:8148332
-
项目类别:
-
资助金额:$21.76万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Different Therapeutic Approaches forTreatment of Chronic Heart Failure
-
批准号:8335936
-
项目类别:
-
资助金额:$43.53万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment
-
批准号:8552488
-
项目类别:
-
资助金额:$79.76万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Vacular type of Ehlers-Danlos Syndrome: experimental models and treatment
-
批准号:7732334
-
项目类别:
-
资助金额:$55.02万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Different Therapeutic Approaches forTreatment of Chronic Heart Failure
-
批准号:8148325
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Behavioral, dietary and pharmacological modalities of cardioprotection
-
批准号:8148333
-
项目类别:
-
资助金额:$18.5万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Behavioral, dietary and pharmacological modalities of cardioprotection
-
批准号:8552490
-
项目类别:
-
资助金额:$29.91万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment
-
批准号:8335942
-
项目类别:
-
资助金额:$81.26万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:7964068
-
项目类别:
-
资助金额:$13.78万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Reduction of myocardial damage during acute ischemia
-
批准号:8335943
-
项目类别:
-
资助金额:$34.82万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Behavioral, dietary and pharmacological modalities of cardioprotection
-
批准号:8335944
-
项目类别:
-
资助金额:$31.92万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment
-
批准号:8148331
-
项目类别:
-
资助金额:$55.5万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Vacular type of Ehlers-Danlos Syndrome: experimental models and treatment
-
批准号:7964067
-
项目类别:
-
资助金额:$81.32万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Different Therapeutic Approaches forTreatment of Chronic Heart Failure
-
批准号:8552482
-
项目类别:
-
资助金额:$39.88万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure
-
批准号:8552316
-
项目类别:
-
资助金额:$39.88万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
Behavioral, dietary and pharmacological modalities of cardioprotection
-
批准号:7732336
-
项目类别:
-
资助金额:$11.38万
-
财政年份:--
-
负责人:Mark Talan
-
依托单位:
海外基金